Download PDF
Zeitschrift für Orthomolekulare Medizin 2021; 19(01): 10-14
DOI: 10.1055/a-1374-5344
Wissen

Prävention bei Frauen ab 50 – Ernährung und Hormone im Alter

Bernd Kleine-Gunk
› Further Information
    Permissions and Reprints

Zusammenfassung

Hormonmangel bei Frauen in der Postmenopause beschleunigt Alterungsprozesse und ist damit neben der biologischen Alterung ein Risikofaktor für die häufigsten tödlichen Krankheiten. Eine Hormonersatztherapie mit Östrogenen schützt jüngere, gefäßgesunde Frauen vor späteren kardiovaskulären Erkrankungen und nach neueren Studien auch vor Demenz. Die Häufigkeit von Oberschenkelhalsfrakturen kann ebenfalls durch Hormongaben reduziert werden. Daneben beeinflussen auch Lebensstil und Ernährung Morbidität und Mortalität. Normalgewicht und eine ausreichende Zufuhr von ω-3-Fettsäuren sowie antioxidativen und antiinflammatorischen Substanzen aus Obst und Gemüse haben protektive Wirkungen. Kalzium, Vitamin D und Muskeltraining schützen vor Osteoporose.

Schlüsselwörter

Altern - Postmenopause - Ernährung - Hormone - kardiovaskuläre Erkrankungen - Hormonersatztherapie - Östrogen - Krebs - Soja - Osteoporose - Kalzium - Vitamin D - Demenz


Publication History

Article published online:
01 April 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 GBD 2019 Risk Factors Collaborators,. Murray CJL. et al. Global Burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Diseases Study 2019. Lancet 2020; 396: 1223-1249
    CrossrefPubMedGoogle Scholar
  • 2 Vos H, Bor H, Rangelrooij-Minkels M, Schellevis F, Lagro-Jansen A. Multimorbidity in older women: the negative impact of specific combinations of chronic conditions on self-rated health. Eur J Gen Pract 2013; 1 (02) : 117-122
    CrossrefPubMedGoogle Scholar
  • 3 Rossouw JE, Anderson GL, Prentice RL. et al.; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288 (03) : 321-333
    CrossrefPubMedGoogle Scholar
  • 4 Rossouw JE, Prentice RL, Manson JAE. et al. Postmenopausal Hormone Therapy and Risk of Cardiovaskular Disease by Age and Years Since Menopause. JAMA 2007; 297 (13) : 1465-1477
    CrossrefPubMedGoogle Scholar
  • 5 Eckel R, Jakicic J, Ard J. et al. 2013 AHA / ACC guideline on lifestyle management to reduce cardiovascular risk. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (25 suppl 2): 100-101
    CrossrefPubMedGoogle Scholar
  • 6 Neuhouser M, Wassertheil-Smoller S, Thomson C. et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women’s Health Initiative cohorts. Arch Intern Med 2009; 169 (03) : 294-304
    CrossrefPubMedGoogle Scholar
  • 7 Manson JE. et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013; 310: 1353-1368
    CrossrefPubMedGoogle Scholar
  • 8 Thomson C. Diet and breast cancer: understanding risks and benefits. Nutr Clin Pract 2012; 27 (05) : 636-650
    CrossrefPubMedGoogle Scholar
  • 9 Ziegler RG, Hoover RN, Pike MC. et al. Migration patterns and breast cancer risk in Asian-American women. J Natl cancer Inst 1993; 85: 1819-1827
    CrossrefPubMedGoogle Scholar
  • 10 Cassidy A, Albertazzi P, Nielsen I. et al. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 2006; 65: 76-92
    CrossrefPubMedGoogle Scholar
  • 11 Hadji P, Klein S, Gothe H. et al. The epidemiology of osteopotosis – Bone Evaluation Study (BEST): an analysis of routine health insurance data. Dtsch Ärztebl Int 2013; 110 (04) : 52-57
    PubMedGoogle Scholar
  • 12 Showers M, Crutchfield M, Bandekar R. et al. Bone mineral density and its change in pre- and perimenopausal white women: The Michigan Health Study. J Bone Min Res 1998; 13 (07) : 1134-1140
    CrossrefPubMedGoogle Scholar
  • 13 Malabanan A, Holick M. Vitamin D and bone health in postmenopausal women. J Women Health 2003; 12 (02) : 151-156
    CrossrefPubMedGoogle Scholar
  • 14 Prince M. et al. World Alzheimer Report 2015. The Global Impact of Dementia. An anlysis of prevalence, incidence, cost and trend. Alzheimers Disease International. 2015 www.alzint.org/u/WorldAlzheimerReport2015.pdf
    PubMedGoogle Scholar
  • 15 Shumaker S. et al. Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairmant in Postmenopausal Women. JAMA 2003; 189: 2651-2662
    CrossrefPubMedGoogle Scholar
  • 16 Gleason CE. et al. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Control KEEPS- Cognitive and Affective Study. PLos Med 2015; 12
    Google Scholar
  • 17 Loef M, Walach H. Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies. J Nutr Health Aging 2012; 16 (07) : 626-630
    CrossrefPubMedGoogle Scholar